Related Experiment Videos
Search for picornaviruses at onset of inflammatory myopathy
Abstract:
Picornaviruses may not play a role as persistent agents in the inflammatory myopathies, but it is still thought likely that they may act as triggers of an autoimmune process. Forty one muscle biopsy specimens, taken from three weeks to six months (mean four months) after onset, were examined using three different picornaviral primers and PCR. Moderate to severe disease activity was evident in all specimens. The results were compared with those of 18 biopsy specimens examined later in the disease course, and with specimens from 27 patients with non-inflammatory myopathies. All results were negative. Thus, even as early as three weeks after clinical disease appears, picornaviruses are not detectable in these disorders.
Insights
Picornaviruses are unlikely to be persistent agents in inflammatory myopathies. This study found no detectable picornaviruses in muscle biopsies, even early in the disease course, suggesting they do not cause these autoimmune disorders.
Area of Science:
- Virology
- Immunology
- Neurology
Background:
- Inflammatory myopathies are debilitating autoimmune disorders affecting muscles.
- Picornaviruses have been hypothesized as potential triggers for autoimmune processes in these conditions.
Purpose of the Study:
- To investigate the presence of picornaviruses in muscle biopsy specimens from patients with inflammatory myopathies.
- To determine if picornaviruses act as persistent agents or early triggers in the pathogenesis of inflammatory myopathies.
Main Methods:
- Polymerase Chain Reaction (PCR) was employed to detect picornaviral RNA.
- Three distinct picornaviral primers were utilized.
- Muscle biopsy specimens were analyzed from patients at various stages of inflammatory myopathy and from controls with non-inflammatory myopathies.
Main Results:
- No picornaviruses were detected in any of the 41 muscle biopsy specimens from patients with inflammatory myopathies, regardless of disease duration (three weeks to six months post-onset).
- Comparison with 18 later-stage disease specimens and 27 non-inflammatory myopathy controls also yielded negative results.
- The absence of detectable picornaviruses suggests they are not present as persistent agents in these disorders.
Conclusions:
- Picornaviruses are unlikely to be persistent infectious agents in inflammatory myopathies.
- The findings do not support the hypothesis that picornaviruses play a direct role in the pathogenesis of inflammatory myopathies.
- Further research may be needed to explore other potential triggers for the autoimmune processes involved in inflammatory myopathies.